Abstract
35 women with diffuse fibrous-cystic mastopathy were treated with gestagen slow-releasing drug "Depo-Provera". Use of the drug made part of the patients feel better and promoted regression of objective signs of the disease. Conclusion was made that administration of the drug in mastopathy caused by hormonal disorders is pathogenetically substantiated method of treatment.
Publication types
-
Comparative Study
-
English Abstract
MeSH terms
-
Adult
-
Estradiol / blood
-
Female
-
Fibrocystic Breast Disease / blood
-
Fibrocystic Breast Disease / drug therapy*
-
Humans
-
Medroxyprogesterone Acetate / therapeutic use*
-
Menstrual Cycle / blood
-
Menstrual Cycle / drug effects
-
Menstruation Disturbances / blood
-
Menstruation Disturbances / drug therapy*
-
Progesterone / blood
-
Prolactin / blood
-
Prolactin / drug effects
-
Remission Induction
Substances
-
Progesterone
-
Estradiol
-
Prolactin
-
Medroxyprogesterone Acetate